CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $18.15M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 12.03: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.18%
Annual Rate
INR 0.67Paid unknown
Payout Ratio
15.0%Sustainable
Last Ex-Dividend
Sep 4, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
41.61BINR434.81M · vs all stocks (USD)
Trailing P/E
83.70xRevenue (TTM)
1.74BINR18.15M · vs all stocks (USD)
Profit Margin
28.02%Beta
0.4870xvs all stocks
52-Week Change
-4.52%vs all stocks
Forward Annual Dividend Yield
0.18%vs all stocks
Market Capitalization
41.61BINR434.81M · vs all stocks (USD)
Enterprise Value
41.79BINR436.69M · vs all stocks (USD)
Trailing P/E
83.70xPrice to Sales (TTM)
23.30xPrice to Book (MRQ)
14.04xEnterprise to Revenue
24.05xEnterprise to EBITDA
50.56xGross Margin
88.92%Profit Margin
28.02%Operating Margin
38.41%Return on Assets (TTM)
9.27%Return on Equity (TTM)
16.22%Revenue (TTM)
1.74BINR18.15M · vs all stocks (USD)
Revenue per Share (TTM)
15.95INRUpdated Aug 21, 2026Quarterly Revenue Growth
22.10%Gross Profit (TTM)
1.16BINR12.15M · vs all stocks (USD)
EBITDA (TTM)
779.58MINR8.15M · vs all stocks (USD)
Net Income (TTM)
486.87MINR5.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
22.10%Operating Cash Flow (TTM)
487.77MINR5.10M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
466.87MINR4.88M · vs all stocks (USD)
Forward Annual Dividend Rate
0.6700INRUpdated Aug 21, 2026Forward Annual Dividend Yield
0.18%vs all stocks
Trailing Annual Dividend Rate
0.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
14.99%Revenue
1.66BINRFY2026 · Mar 31, 2026Cost of Goods Sold
275.79MINRFY2026 · Mar 31, 2026Gross Profit
1.38BINRFY2026 · Mar 31, 2026Operating Income
626.11MINR6.54M · vs all stocks (USD)
Pre-tax Income
620.90MINRFY2026 · Mar 31, 2026Income Tax Expense
154.09MINRFY2026 · Mar 31, 2026Net Income
466.87MINRFY2026 · Mar 31, 2026EBIT
650.39MINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
779.58MINRFY2026 · Mar 31, 2026Other Operating Expenses
462.03MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
29.49MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
240.31MINRFY2026 · Mar 31, 2026Free Cash Flow
-1.49BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
31.21MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
620.90MINRFY2026 · Mar 31, 2026Other Non-cash Items
24.55MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-296.78MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-108.36MINRFY2026 · Mar 31, 2026Capital Expenditures
-1.73BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-1.73BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
1.30BINRFY2026 · Mar 31, 2026Common Dividends Paid
-73.01MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
1.23BINRFY2026 · Mar 31, 2026Shares Outstanding
108.97MSharesUpdated Aug 21, 2026Float Shares
29.47MSharesUpdated Aug 21, 2026% Held by Insiders
71.98%vs all stocks
% Held by Institutions
1.19%vs all stocks
Total Cash (MRQ)
60.88MINR636.09K · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5590INRUpdated Aug 21, 2026Total Debt (MRQ)
1.62BINR16.91M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5623xCurrent Ratio (MRQ)
1.12xBook Value per Share (MRQ)
26.41INRUpdated Aug 21, 2026Total Assets
5.03BINR52.60M · vs all stocks (USD)
Total Current Assets
887.84MINRFY2026 · Mar 31, 2026Total Liabilities
2.16BINRFY2026 · Mar 31, 2026Total Non-current Assets
4.15BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
1.37BINRFY2026 · Mar 31, 2026Total Current Liabilities
791.48MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
31.21MINRFY2026 · Mar 31, 2026Other Short-term Investments
32.97MINRFY2026 · Mar 31, 2026Accounts Receivable
609.17MINRFY2026 · Mar 31, 2026Inventory
154.23MINRFY2026 · Mar 31, 2026Accounts Payable
366.54MINRFY2026 · Mar 31, 2026Short-term Debt
330.97MINRFY2026 · Mar 31, 2026Other Current Liabilities
30.54MINRFY2026 · Mar 31, 2026Long-term Debt
1.29BINRFY2026 · Mar 31, 2026Common Stock (Book)
108.97MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
2.88BINR30.07M · vs all stocks (USD)
52-Week Low
225.05INRUpdated Aug 21, 202652-Week High
479.00INRUpdated Aug 21, 202652-Week Change
-4.52%vs all stocks
Beta
0.4870xvs all stocks
50-Day MA
371.83INRUpdated Aug 21, 2026200-Day MA
358.76INRUpdated Aug 21, 2026Avg 10-Day Volume
87.07KSharesUpdated Aug 21, 2026Avg 30-Day Volume
81.35KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
4.43INRUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 12.03: safe zoneNotable
Altman Z-Score: 12.03
High structural barrier to entryNotable
Barrier to Entry: 0.70
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $18.15M, lower than 95% of all stocks globallySignificant
Revenue (USD): 18,154,082.569Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Puma Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Canopy Growth Corporation
Tier 1ProductionApproval-Gated PipelineFlowRule
Evommune, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Avacta Group Plc
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Benitec Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Eupraxia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hubei Goto Biopharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Synergy Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qinghai Spring Medicinal Resources Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Baotou Dongbao Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Kangda New Materials Group Co., Ltd.
1 interpretationReceivables Heavy and Growing
Avery Dennison Corporation
1 interpretationReceivables Heavy and Growing
China Marine Information Systems Company Limited
1 interpretationReceivables Heavy and Growing